A team of researchers in California studied a new multi-cancer early detection test called Galleri, which can reportedly ...

ctDNA-MRD testing better predicted outcomes versus PET/CT scans for large B-cell lymphoma, leading to NCCN guideline updates for remission assessment. A minimal measurable residual disease (MRD) ...

Galleri should have a good chance to win FDA marketing approval in early 2027. But insurance coverage and widespread adoption ...

As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO Prostate Cancer, about the role of PSMA-PET Imaging versus PSA. Prostate specific antigen (PSA) is a ...

HOUSTON -- Leading Texas veterinarians are mobilizing to enlist pets in the testing of experimental cancer therapies, a potential benefit to not just dogs and cats but people. The veterinarians ...

Only MCED test on-market to analyze multiple biomarker classes, enhancing early cancer detection-Offered as a laboratory-developed test at ...

The Sweden-based Phase II trial will evaluate how well the company's gallium-68-labeled PET tracer identifies best responders to Enhertu.